Benchmark reissued their buy rating on shares of Medicine Man Technologies (OTC:SHWZ – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $2.50 price objective on the stock.
Medicine Man Technologies Price Performance
SHWZ opened at $0.18 on Wednesday. Medicine Man Technologies has a 52 week low of $0.01 and a 52 week high of $1.55. The firm’s 50-day moving average is $0.28.
Medicine Man Technologies Company Profile
Featured Articles
- Five stocks we like better than Medicine Man Technologies
- When to Sell a Stock for Profit or Loss
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Roth IRA Calculator: Calculate Your Potential Returns
- MarketBeat Week in Review – 8/12 – 8/16
- How to Start Investing in Real Estate
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Medicine Man Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicine Man Technologies and related companies with MarketBeat.com's FREE daily email newsletter.